Seroprevalence of viral hepatitis B, C and E in TB patients from the Republic of Moldova

One Health & Risk Management Pub Date : 2023-01-01 DOI:10.38045/ohrm.2023.1.07

Octavian Sajin, C. Spînu, M. Isac, Nina Iziumov, Aliona Cherniavska, Alexandru Buga, Igor Ciobanu

{"title":"Seroprevalence of viral hepatitis B, C and E in TB patients from the Republic of Moldova","authors":"Octavian Sajin, C. Spînu, M. Isac, Nina Iziumov, Aliona Cherniavska, Alexandru Buga, Igor Ciobanu","doi":"10.38045/ohrm.2023.1.07","DOIUrl":null,"url":null,"abstract":"Introduction. For the first time, in the Republic of Moldova, there was established the seroprevalence of viral hepatitis B, C and E markers in patients with tuberculosis depending on gender, age and geographical areas. \nMaterial and methods. 200 blood samples were collected from patients with tuberculosis and tested by the immuno-fermentative method for presence of viral hepatitis B, C and E markers. \nResults. Following the investigations, it was established that the seroprevalence of the anti-HEV Ig marker in patients with tuberculosis is 12.0±2.3%. The seroprevalence of viral hepatitis B marker HBsAg in patients with tuberculosis was 13.5±2.4%, and that of viral hepatitis C anti-HCV – 9.0±2.0%. The study of investigations results for the presence of nominated markers depending on the geographical areas showed a significant statistically difference in the seroprevalence of the anti-HEV IgG marker in TB patients in the Central area of the country compared to the Southern area(p<0.05). \nConclusions. Patients with tuberculosis have a higher risk of developing viral hepatitis B, C and E, mainly affecting people aged 40-49 and > 60 years, including males.","PeriodicalId":274368,"journal":{"name":"One Health & Risk Management","volume":"9 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"One Health & Risk Management","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.38045/ohrm.2023.1.07","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction. For the first time, in the Republic of Moldova, there was established the seroprevalence of viral hepatitis B, C and E markers in patients with tuberculosis depending on gender, age and geographical areas. Material and methods. 200 blood samples were collected from patients with tuberculosis and tested by the immuno-fermentative method for presence of viral hepatitis B, C and E markers. Results. Following the investigations, it was established that the seroprevalence of the anti-HEV Ig marker in patients with tuberculosis is 12.0±2.3%. The seroprevalence of viral hepatitis B marker HBsAg in patients with tuberculosis was 13.5±2.4%, and that of viral hepatitis C anti-HCV – 9.0±2.0%. The study of investigations results for the presence of nominated markers depending on the geographical areas showed a significant statistically difference in the seroprevalence of the anti-HEV IgG marker in TB patients in the Central area of the country compared to the Southern area(p<0.05). Conclusions. Patients with tuberculosis have a higher risk of developing viral hepatitis B, C and E, mainly affecting people aged 40-49 and > 60 years, including males.

查看原文本刊更多论文

摩尔多瓦共和国结核病患者中病毒性乙型、丙型和戊型肝炎的血清患病率

介绍。摩尔多瓦共和国首次根据性别、年龄和地理区域确定了结核病患者乙型、丙型和戊型病毒性肝炎标志物的血清流行率。材料和方法。收集200例结核病患者血液样本，采用免疫发酵法检测乙型、丙型和戊型病毒性肝炎标志物的存在。结果。通过调查，确定结核患者中抗hev Ig标记物的血清阳性率为12.0±2.3%。结核患者血清乙型病毒性肝炎标志物HBsAg阳性率为13.5±2.4%，丙型病毒性肝炎抗hcv阳性率为- 9.0±2.0%。根据地理区域对指定标记物存在情况的调查结果进行的研究显示，该国中部地区与南部地区(60岁，包括男性)的结核病患者中抗戊肝病毒IgG标记物的血清阳性率有显著的统计学差异。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

One Health & Risk Management

自引率

0.00%

发文量